Production of new amilorides as potent inhibitors of mitochondrial respiratory complex I

References

• Kleyman TR, Cragoe EJ Jr. Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. 1988;105:1–21.10.1007/BF01871102
   PubMed Web of Science ®Google Scholar
• Putney LK, Denker SP, Barber DL. The changing face of the Na+/H+ exchanger, NHE: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol. 2002;42:527–552.10.1146/annurev.pharmtox.42.092001.143801
   PubMed Web of Science ®Google Scholar
• Nakamaru-Ogiso E, Seo BB, Yagi T, Matsuno-Yagi A. Amiloride inhibition of the proton-translocating NADH-quinone oxidoreductase of mammals and bacteria. FEBS Lett. 2003;549:43–46.10.1016/S0014-5793(03)00766-X
   PubMed Web of Science ®Google Scholar
• Stolpe S, Friedrich T. The Escherichia coli NADH: ubiquinone oxidoreductase (complex I) is a primary proton pump but may be capable of secondary sodium antiport. J. Biol. Chem. 2004;279:18377–18383.10.1074/jbc.M311242200
   PubMed Web of Science ®Google Scholar
• Efremov RG, Baradaran R, Sazanov LA. The architecture of respiratory complex I. Nature. 2010;465:441–445.10.1038/nature09066
   PubMed Web of Science ®Google Scholar
• Efremov RG, Sazanov LA. Structure of the membrane domain of respiratory complex I. Nature. 2011;476:414–420.10.1038/nature10330
   PubMed Web of Science ®Google Scholar
• Baradaran R, Berrisford JM, Minhas GS, Sazanov LA. Crystal structure of the entire respiratory complex I. Nature. 2013;494:443–448.10.1038/nature11871
   PubMed Web of Science ®Google Scholar
• Murai M, Mashimo Y, Hirst J, Miyoshi H. Exploring interactions between the 49 kDa and ND1 subunits in mitochondrial NADH-ubiquinone oxidoreductase (complex I) by photoaffinity labeling. Biochemistry. 2011;50:6901–6908.10.1021/bi200883c
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Murai M, Sakiyama N, Ifuku K, Miyoshi H. Fenpyroximate binds to the interface between PSST and 49 kDa subunits in mitochondrial NADH-ubiquinone oxidoreductase. Biochemistry. 2012;51:1953–1963.10.1021/bi300047h
   PubMed Web of Science ®Google Scholar
• Cragoe EJ Jr, Woltersdorf OW Jr, Bicking JB, Kwong SF, Jones JH. Pyrazine diuretics II. N-amidino-3-amino-5-substituted 6-halopyrazinecarboxamides. J. Med. Chem. 1967; 10: 66–75.10.1021/jm00313a014
   PubMed Web of Science ®Google Scholar
• Matthews H, Ranson M, Tyndall JDA, Kelso MJ. Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA). Bioorg. Med. Chem. Lett. 2011;21:6760–6766.10.1016/j.bmcl.2011.09.044
   PubMed Web of Science ®Google Scholar
• Hirsh AJ, Molino BF, Zhang J, Astakhova N, Geiss WB, Sargent BJ, Swenson BD, Usyatinsky A, Wyle MJ, Boucher RC, Smith RT, Zamurs A, Johnson MR. Design, synthesis, and structure−activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis. J. Med. Chem. 2006;49:4098–4115.10.1021/jm051134w
   PubMed Web of Science ®Google Scholar
• Secondo A, Pannaccione A, Molinaro P, Ambrosino P, Lippiello P, Esposito A, Cantile M, Khatri PR, Melisi D, Di Renzo GD, Annunziato L. Molecular pharmacology of the amiloride analog 3-amino-6- chloro-5-[(4-chloro-benzyl)amino]-N-[[(2,4-dimethylbenzyl)-amino]iminomethyl]-pyrazinecarboxamide (CB-DMB) as a pan inhibitor of the Na+-Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in stably transfected cells. J. Pharmacol. Exp. Ther. 2009;331:212–221.10.1124/jpet.109.152132
   PubMed Web of Science ®Google Scholar
• Hunt, T, Atherton-Watson HC, Axford J, Collingwood SP, Coote KJ, Cox B, Czarnecki S, Danahay H, Devereux Na, Howsham C, Hunt P, Paddock V, Paisley D, Young A. Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines. Bioorg. Med. Chem. Lett. 2012;22:929–932.10.1016/j.bmcl.2011.12.016
   PubMed Web of Science ®Google Scholar
• Matsuno-Yagi A, Hatefi Y. Studies on the mechanism of oxidative phosphorylation. J Biol. Chem. 1985;260:11424–11427.
   PubMed Web of Science ®Google Scholar
• Murai M, Ichimaru N, Abe M, Nishioka T, Miyoshi H. Mode of inhibitory action of Δlac-acetogenins, a new class of inhibitors of bovine heart mitochondrial complex I. Biochemistry. 2006;45:9778–9787.10.1021/bi060713f
   PubMed Web of Science ®Google Scholar
• Nakanishi S, Abe M, Yamamoto S, Murai M, Miyoshi H. Bis-THF motif of acetogenin binds to the third matrix-side loop of ND1 subunit in mitochondrial NADH-ubiquinone oxidoreductase. Biochim. Biophys. Acta. 2011;1807:1170–1176.10.1016/j.bbabio.2011.05.012
   PubMed Web of Science ®Google Scholar
• Masuya T, Murai M, Ifuku K, Morisaka H, Miyoshi H. Site-specific chemical labeling of mitochondrial respiratory complex I through ligand-directed tosylate chemistry. Biochemistry. 2014;53:2307–2317.10.1021/bi500205x
   PubMed Web of Science ®Google Scholar